John W. Davis, MD, FACS

Peer-Reviewed Articles

1. Lawen, T, Garcia, RS, Smith, MT, Pyo, J, Higgason, N, Robert, M, Chapin, BF, Chery, LJ, Davis, JW, Ward, JF, Pisters, LL, Pettaway, CA, Hahn, AW, Frigo, DE, Wei, P, Daniel-MacDougall, CR, Gregg, JR. Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance. Journal of Urology Publish Ahead of Print, 2026. e-Pub 2026. PMID: 41662578.
2. Davis, JW, Aragaki, A, Harrington, LB, Rossouw, J, Wells, G, Shadyab, AH, Schnatz, PF, Shufelt, CL, Warsinger-Martin, L, Wild, RA, Manson, JE. Baseline use of aspirin or statins with oral estrogen and progestogens to prevent incident arterial or venous thrombotic events. Menopause 33(2):134-144, 2026. e-Pub 2026. PMID: 41117635.
3. Zurita-Saavedra, A, Tidwell, R, Chapin, BF, Harris, DR, Zhang, M, Pisters, LL, Aparicio, A, Araujo, JC, Arce-Gallego, S, Zhu, K, Lozano, ML, Pagliaro, LC, Mateo, J, Logothetis, CJ, Troncoso, P, Davis, JW. Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis. European Urology Oncology 8(4):1010-1019, 2025. e-Pub 2025. PMID: 40651932.
4. Cui, Z, Ma, R, Yang, CH, Malpani, A, Chu, TN, Ghazi, A, Davis, JW, Miles, B, Lau, C, Liu, Y, Hung, AJ. Capturing relationships between suturing sub-skills to improve automatic suturing assessment. npj Digital Medicine 7(1), 2024. e-Pub 2024. PMID: 38862627.
5. Gregg, JR, Newcomb, LF, Wu, R, Dennison, JB, Davis, JW, Pettaway, CA, Pisters, L, Ward, JF, Chapin, BF, Chery, LJ, Urkmez, A, Fang, A, Higgason, N, Troncoso, P, Daniel-MacDougall, CR, Logothetis, CJ, Thompson, TC, Hahn, AW, Liu, M, Zheng, Y, Lin, DW, Hanash, SM, Irajizad, E, Fahrmann, JF. Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance. Biomarker Research 12(1), 2024. e-Pub 2024. PMID: 39522029.
6. Hahn, AW, Manyam, GC, Chapin, BF, Zhang, M, Yu, Y, Pettaway, CA, Chery, LJ, Pisters, LL, Ward, JF, Gregg, JR, Papadopoulos, JN, Kamat, A, Lozano, M, Hoang, A, Broom, BM, Wang, X, Huff, C, Logothetis, CJ, Troncoso, P, Pilie, PG, Davis, JW. A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. BJU International 134(3):449-458, 2024. e-Pub 2024. PMID: 38837608.
7. Sosa, A, Rooney, MK, Thames, HD, Sanders, JW, Swanson, DM, Choi, S, Nguyen, Q, Mok, H, Kuban, DA, Ron Zhu, X, Shah, SJ, Mayo, LL, Hoffman, K, Tang, C, McGuire, SE, Sahoo, N, Zhang, X, Lee, AK, Pugh, T, Mahmood, U, Davis, JW, Chapin, BF, Corn, P, Kudchadker, R, Ausat, N, Frank, SJ. Proton therapy toxicity outcomes for localized prostate cancer. Clinical and Translational Radiation Oncology 48, 2024. e-Pub 2024. PMID: 39188999.
8. Bancroft, EK, Page, EC, Brook, MN, Pope, J, Thomas, S, Myhill, K, Helfand, BT, Talaty, P, Ong, KR, Douglas, E, Cook, J, Rosario, DJ, Salinas, M, Buys, S, Anson, J, Davidson, R, Longmuir, M, Side, L, Eccles, D, Tischkowitz, M, Taylor, A, Cruellas, M, Ballestero, EP, Cleaver, R, Varughese, M, Barwell, J, LeButt, M, Greenhalgh, L, Hart, R, Azzabi, A, Jobson, I, Cogley, L, Evans, G, Rothwell, J, Taylor, N, Hogben, M, Saya, S, Kote-Jarai, Z, Ardern-Jones, A, Bangma, CH, Castro, E, Dearnaley, D, Eyfjörd, JE, Falconer, A, Foster, C, Gronberg, H, Axkrona, K, Arun, BK, Strom, SS, Davis, JW. The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers. BJU International 134(3):484-500, 2024. e-Pub 2024. PMID: 38839570.
9. Anselmino, N, Labanca, E, Shepherd, P, Dong, J, Yang, J, Song, X, Nandakumar, S, Kundra, R, Lee, CJ, Schultz, N, Zhang, J, Araujo, JC, Aparicio, A, Subudhi, SK, Corn, P, Pisters, LL, Ward, JF, Davis, JW, Vazquez, ES, Gueron, G, Logothetis, CJ, Futreal, A, Troncoso, P, Chen, Y, Navone, NM. Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series. Clinical Cancer Research 30(10):2272-2285, 2024. e-Pub 2024. PMID: 38488813.
10. Gregg, JR, Magill, RG, Fang, AM, Chapin, BF, Davis, JW, Adibi, M, Chery, LJ, Papadopoulos, JN, Pettaway, CA, Pisters, LL, Ward, J, Hahn, AW, Daniel-MacDougall, CR, Bhaskaran, J, Zhu, K, Guerrero, M, Zhang, M, Troncoso, P. The association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urologic Oncology: Seminars and Original Investigations 42(4):116.e1-116.e7, 2024. e-Pub 2024. PMID: 38262868.
11. Bryce AH, Crawford ED, Agarwal N, Hussain MH, Beltran H, Cooperberg MR, Petrylak DP, Shore N, Spratt DE, Tagawa ST, Antonarakis ES, Aparicio AM, Armstrong AJ, Boike TP, Calais J, Carducci MA, Chapin BF, Cookson MS, Davis JW, Dorff T, Eggener SE, Feng FY, Gleave M, Higano C, Iagaru A, Morgans AK, Morris M, Murray KS, Poage W, Rettig MB, Sartor O, Scher HI, Sieber P, Small E, Srinivas S, Yu EY, Zhang T, Koo PJ. Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. JU Open Plus 2(4), 2024. e-Pub 2024. PMID: 38774467.
12. Crawford ED, Bryce AH, Hussain MH, Agarwal N, Beltran H, Cooperberg MR, Petrylak DP, Shore N, Spratt DE, Tagawa ST, Antonarakis ES, Aparicio AM, Armstrong AJ, Boike TP, Calais J, Carducci MA, Chapin BF, Cookson MS, Davis JW, Dorff T, Eggener SE, Feng FY, Gleave M, Higano C, Iagaru A, Morgans AK, Morris M, Murray KS, Poage W, Rettig MB, Sartor O, Scher HI, Sieber P, Small E, Srinivas S, Yu EY, Zhang T, Koo PJ. Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1. JU Open Plus 2(4), 2024. e-Pub 2024. PMID: 38774466.
13. Chu TN, Wong EY, Ma R, Yang CH, Dalieh IS, Hui A, Gomez O, Cen S, Ghazi A, Miles BJ, Lau C, JW D, Goldenberg MG, Hung AJ. A Multi-institution Study on the Association of Virtual Reality Skills with Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Focus 9(6):1044-1051, 2023. e-Pub 2023. PMID: 37277274.
14. Urkmez A, Davis JW. Freehand Versus Grid-based Transperineal Prostate Biopsy: A Comparison of Anatomical Region Yield and Complications. Reply. J Urol 210(2):101097JU0000000000003547, 2023. e-Pub 2023. PMID: 37163220.
15. Leitao MM, Kreaden US, Laudone V, Park BJ, Pappou EP, Davis JW Rice DC, Chang GJ, Rossi EC, Hebert AE, Slee A, Gonen M. The RECOURSE Study: Long-term Oncologic Outcomes Associated with Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, cOlorectal, lUng, or pRoState cancEr: a Systematic Review and meta-analysis. Ann Surg 277(3):387-396, 2023. e-Pub 2023. PMID: 36073772.
16. Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall'Era M, JW D, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw 21(3):236-246, 2023. e-Pub 2023. PMID: 36898362.
17. JW D. Point-Counterpoint: Screening vs Diagnostic Testing: A Focus on the Improved Evaluations and Risk Adapted Strategies for Prostate Biopsy. Urol Pract 10(2):109-110, 2023. e-Pub 2023. PMID: 37103400.
18. Weller SC, JW D, Porterfield L, Chen L, Wilkinson G. Hormone exposure and venous thromboembolism in commercially insured women aged 50 to 64 years. Res Pract Thromb Haemost 7(3):100135, 2023. e-Pub 2023. PMID: 37193125.
19. Westerman, ME, Bree, KK, Msaouel, P, Kukreja, JB, Mantaring, C, Rukundo, I, Gonzalez, MG, Gregg, JR, Casteel, KN, Matin, S, Lafleur, AD, Best, RN, Crump, LD, Cunningham, JM, Saucedo, MA, Valle, DD, Varghese, R, Adibi, M, Chapin, BF, Chery, LJ, Davis, JW, Dinney, CP, Graber, WJ, Kamat, A, Karam, JA, Navai, N, Papadopoulos, JN, Pettaway, CA, Pisters, LL, Smith III, T, Ward, JF, Westney, OL, Wood, CG. Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis. Journal of Urology 208(4):886-895, 2022. e-Pub 2022. PMID: 36082549.
20. Thomas RD, JW D, Cuccaro PM, Gemeinhardt GL. Assessing associations between insecure income and US workers' health: An IPUMS-MEPS analysis. Soc Sci Med 309:115240, 2022. e-Pub 2022. PMID: 35985245.
21. Reisler JD, Ditmars FS, JW D. Addressing a National Health Crisis: A Student-Run Congestive Heart Failure Clinic for Underserved Patients. Acad Med 97(7):949-950, 2022. e-Pub 2022. PMID: 34469350.
22. Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, JW D, Eggener S, Horwitz EM, Kane CJ, Kirkby E, Lin DW, McBride SM, Morgans AK, Pierorazio PM, Rodrigues G, Wong WW, Boorjian SA. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions. J Urol 208(1):26-33, 2022. e-Pub 2022. PMID: 35536141.
23. Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, JW D, Eggener S, Horwitz EM, Kane CJ, Kirkby E, Lin DW, McBride SM, Morgans AK, Pierorazio PM, Rodrigues G, Wong WW, Boorjian SA. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. J Urol 208(1):10-18, 2022. e-Pub 2022. PMID: 35536144.
24. Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, JW D, Eggener S, Horwitz EM, Kane CJ, Kirkby E, Lin DW, McBride SM, Morgans AK, Pierorazio PM, Rodrigues G, Wong WW, Boorjian SA. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up. J Urol 208(1):19-25, 2022. e-Pub 2022. PMID: 35536148.
25. JW D. Seasonal events and journal milestones. BJUI Compass 3(4):259-262, 2022. e-Pub 2022. PMID: 35783594.
26. Ajay, D, Li, H, Barrett-Harlow, BL, Nguyen, JN, Benson, CR, Wang, X, Chapin, BF, Davis, JW, Westney, OL. Perioperative factors contributing to delayed return of continence after radical prostatectomy. Continence 2, 2022. e-Pub 2022.
27. Ballantyne CM, JW D. Exercise and Mortality in Heart Disease Cohorts: Meta-Analysis to Augment Available Evidence. J Am Coll Cardiol 79(17):1701-1703, 2022. e-Pub 2022. PMID: 35483758.
28. JW D, Wang B, Tomczak E, Chi-Fu C, Harmouch W, Reynoso D, Keiser P, Cabada MM. Prediction of the need for intensive oxygen supplementation during hospitalisation among subjects with COVID-19 admitted to an academic health system in Texas: a retrospective cohort study and multivariable regression model. BMJ Open 12(3):e058238, 2022. e-Pub 2022. PMID: 35361651.
29. Mustafa, MO, Ward, JF, Davis, JW, Pettaway, CA, Pisters, LL. Transperineal saturation prostate biopsy in treated and untreated patients. Palestinian Medical and Pharmaceutical Journal 5(2):117-124, 2022. e-Pub 2022.
30. Altok M, Demirel C, Kang HC, Choi H, John D, Inguillo IA, JW D, Ward JF. Impact of MRI/US fusion-guided prostate biopsy on biopsy-naïve patients: A single urologist's experience. BJUI Compass 3(1):19-25, 2022. e-Pub 2022. PMID: 35475153.
31. Shapiro DD, JW D, Williams WH, Chapin BF, Ward JF, Pettaway CA, Gregg JR. Increased body mass index is associated with operative difficulty during robot-assisted radical prostatectomy. BJUI Compass 3(1):68-74, 2022. e-Pub 2022. PMID: 35475154.
32. Spetsieris, N, Boukovala, M, Alafis, I, Davis, JW, Zurita-Saavedra, A, Wang, X, Tu, S, Chapin, BF, Aparicio, A, Corn, P, Wang, J, Subudhi, SK, Araujo, JC, Papadopoulos, JN, Pruitt, L, Weldon, J, Logothetis, CJ, Efstathiou, E. Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer. European Journal of Cancer 157:259-267, 2021. e-Pub 2021. PMID: 34536949.
33. Urkmez A, Demirel C, Altok M, Bathala TK, Shapiro DD, JW D. Freehand versus Grid-Based Transperineal Prostate Biopsy: A Comparison of Anatomical Region Yield and Complications. J Urol 206(4):894-902, 2021. e-Pub 2021. PMID: 34100650.
34. Vanstrum, EB, Ma, R, Maya-Silva, J, Sanford, D, Nguyen, JH, Lei, X, Chevinksy, M, Ghoreifi, A, Han, J, Polotti, CF, Powers, R, Yip, W, Zhang, M, Aron, M, Collins, JW, Daneshmand, S, Davis, JW, Desai, MM, Gerjy, R, Goh, AC, Hu, JC, Kimmig, R, Lendvay, TS, Porter, J, Sotelo, R, Sundaram, CP, Cen, S, Gill, IS, Hung, AJ. Development and Validation of an Objective Scoring Tool to Evaluate Surgical Dissection. Urology Practice 8(5):596-604, 2021. e-Pub 2021.
35. Gregg JR, Borregales LD, Choi H, Lozano M, McRae SE, Venkatesan AM, JW D, Nogueras-Gonzalez GM, Pisters LL, Ward JF. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. World J Urol 39(9):3259-3264, 2021. e-Pub 2021. PMID: 33454813.
36. Altok M, Chapin BF, Matin SF, Achim MF, Gregg JR, JW D. Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase. Urology 155:144-151, 2021. e-Pub 2021. PMID: 33676955.
37. Vanstrum EB, Ma R, Maya-Silva J, Sanford D, Nguyen JH, Lei X, Chevinksy M, Ghoreifi A, Han J, Polotti CF, Powers R, Yip W, Zhang M, Aron M, Collins J, Daneshmand S, Davis JW, Desai MM, Gerjy R, Goh AC, Hu JC, Kimmig R, Lendvay TS, Porter J, Sotelo R, Sundaram CP, Cen S, Gill IS, Hung AJ. Reply by Authors. Urol Pract 8(5):604, 2021. e-Pub 2021. PMID: 37145414.
38. Vanstrum EB, Ma R, Maya-Silva J, Sanford D, Nguyen JH, Lei X, Chevinksy M, Ghoreifi A, Han J, Polotti CF, Powers R, Yip W, Zhang M, Aron M, Collins J, Daneshmand S, Davis JW, Desai MM, Gerjy R, Goh AC, Kimmig R, Lendvay TS, Porter J, Sotelo R, Sundaram CP, Cen S, Gill IS, Hung AJ. Development and validation of an objective scoring tool to evaluate surgical dissection: Dissection Assessment for Robotic Technique (DART). Urol Pract 8(5):596-604, 2021. e-Pub 2021. PMID: 37131998.
39. JW D, Weller SC. Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patients. BMJ Open 11(6):e043714, 2021. e-Pub 2021. PMID: 34130955.
40. Marra, G, Karnes, RJ, Calleris, G, Oderda, M, Alessio, P, Palazzetti, A, Battaglia, A, Pisano, F, Munegato, S, Munoz, F, Filippini, C, Ricardi, U, Linares, E, Sanchez-Salas, R, Goonewardene, S, Dasgupta, P, Challacombe, B, Popert, R, Cahill, D, Gillatt, D, Persad, R, Palou, J, Joniau, S, Smelzo, S, Piéchaud, T, De La Taille, A, Rouprêt, M, Albisinni, S, van Velthoven, R, Morlacco, A, Vidit, S, Gandaglia, G, Mottrie, A, Smith, JA, Joshi, S, Fiscus, G, Berger, A, Aron, M, de Castro Abreu, AL, Gill, IS, Van Der Poel, H, Tilki, D, Murphy, DG, Lawrentschuk, N, Davis, JW, Gontero, P. Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era. Urologic Oncology: Seminars and Original Investigations 39(5):296.e21-296.e29, 2021. e-Pub 2021. PMID: 33436329.
41. JW D. Re: Randomized Comparison of Techniques for Control of the Dorsal Venous Complex During Robot-assisted Laparoscopic Radical Prostatectomy. Eur Urol 79(5):702-703, 2021. e-Pub 2021. PMID: 33384201.
42. Wilkins LJ, Tosoian JJ, Reichard CA, Sundi D, Ranasinghe W, Alam R, Schwen Z, Reddy C, Allaf M, JW D, Chapin BF, Ross AE, Klein EA, Nyame YA. Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy. Cancer 127(9):1425-1431, 2021. e-Pub 2021. PMID: 33721334.
43. Chang CM, McIntosh AG, Shapiro DD, JW D, Ward JF, Gregg JR. Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?. BJUI Compass 2(3):188-193, 2021. e-Pub 2021. PMID: 35475129.
44. Shapiro DD, Gregg JR, Lim AH, Nogueras-González GM, Choi H, Kang HC, Inguillo IA, Chapin BF, JW D, Ward JF. Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance. BJU Int 127(3):340-348, 2021. e-Pub 2021. PMID: 32357283.
45. Gregg JR, Zhang X, Chapin BF, Ward JF, Kim J, JW D, Daniel CR. Adherence to the Mediterranean diet and grade group progression in localized prostate cancer: An active surveillance cohort. Cancer 127(5):720-728, 2021. e-Pub 2021. PMID: 33411364.
46. Beach MW, Kearns KL, JW D, Stutzman JR, Lee D, Lai Y, Monaenkova D, Kram S, Hu J, Lukas C. Stability Assessment of a Polymeric Brominated Flame Retardant in Polystyrene Foams under Application-Relevant Conditions. Environ Sci Technol 55(5):3050-3058, 2021. e-Pub 2021. PMID: 33550796.
47. Ranasinghe W, Shapiro DD, Hwang H, Wang X, Reichard CA, Elsheshtawi M, Achim MF, Bathala T, Tang C, Aparicio A, Tu SM, Navone N, Thompson TC, Pisters L, Troncoso P, JW D, Chapin BF. Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies. Eur Urol 79(2):298-306, 2021. e-Pub 2021. PMID: 33279304.

Invited Articles

1. Ghazi A, Bjurlin M, Link R, Porpiglia F, JW D. AUA 2021 Panel Discussion: Image guided surgery: a focus on simulation and planning in partial nephrectomy. AUA News, 2022. e-Pub 2022.
2. JW D. Out of Office: How a urologist’s hobby progressed from photographing kids’ activities to urology meetings to wildlife. AUA News, 2022. e-Pub 2022.
3. JW D. Pelvic lymphocele post-radical prostatectomy: How to prevent and how to treat?. AUA News, 2022. e-Pub 2022.
4. JW D. Section and Specialty Meetings: Welcoming all to the 101st South Central AUA Annual Meeting for 2022. AUA News, 2022. e-Pub 2022.

Review Articles

1. Redman AD, Bietz J, JW D, Lyon D, Maloney E, Ott A, Otte JC, Palais F, Parsons JR, Wang N. Moving persistence assessments into the 21st century: A role for weight-of-evidence and overall persistence. Integr Environ Assess Manag 18(4):868-887, 2022. e-Pub 2022. PMID: 34730270.
2. Ranasinghe W, Shapiro DD, Zhang M, Bathala T, Navone N, Thompson TC, Broom B, Aparicio A, Tu SM, Tang C, JW D, Pisters L, Chapin BF. Optimizing the diagnosis and management of ductal prostate cancer. Nat Rev Urol 18(6):337-358, 2021. e-Pub 2021. PMID: 33824525.
3. Albaeni A, JW D, Ahmad M. Echocardiographic evaluation of the Athlete's heart. Echocardiography 38(6):1002-1016, 2021. e-Pub 2021. PMID: 33971043.

Other Articles

1. Davis, JW Editorial Commentary*-*********************chk. Urology Practice 9(4):304, 2022. PMID: 37145789.

Editorials

1. Davis, JW. Multiparametric Magnetic Resonance Imaging with Targeted-only Biopsy—A New Standard for Guidelines on Prostate Cancer Detection?. European urology 87(5):524-525, 2025. PMID: 39668104.
2. Davis, JW. The Future of Surgical Skills Evaluation. Urology Practice 11(1):1-2, 2024. PMID: 37902185.
3. JW D. Shining a little light on peer review debates. BJUI Compass 3(5):319-323, 2022. PMID: 35950039.
4. JW D. 2022 May Editorial: 'The Unfair Reviewer Comments'. BJUI Compass 3(3):193-196, 2022. PMID: 35492228.
5. JW D. Adapting to the long pandemic. BJUI Compass 3(2):95-98, 2022. PMID: 35474723.
6. JW D. Behind the scenes. BJUI Compass 3(1):3-5, 2022. PMID: 35475159.
7. JW D. Editorial comment; on Successful same-day discharge for robot-assisted radical prostatectomy: a systematic review and meta-analysis. Urology Practice 9:304, 2022.
8. JW D. BJUI Compass 2021 year-end review. BJUI Compass 2(6):357-358, 2021. PMID: 35474699.
9. JW D. Chasing the elusive goal. BJUI Compass 2(5):303-305, 2021. PMID: 35474878.
10. JW D. July in academic medicine-The hails and the farewells. BJUI Compass 2(4):221-225, 2021. PMID: 35475298.
11. JW D. A shout-out to middle authors: Opportunities for achieving clarity in editing. BJUI Compass 2(3):137-139, 2021. PMID: 35475130.
12. JW D. Editorial Comment. J Urol 205(4):1088, 2021. PMID: 33493000.
13. JW D. Eye of the beholder-Tales from Prostate Cancer Active Surveillance Development. BJUI Compass 2(2):67-70, 2021. PMID: 35474885.

Book Chapters

1. Demirel, HC, Davis, JW. Robot Assisted Radical Prostatectomy, 189-204, 2025.
2. Davis, JW, Tuerk, IA, Deger, S, Loening, S. Minimally invasive treatments for bladder cancer-from transurethral resection to laparoscopic radical cystectomy, 231-240, 2024.
3. Urkmez, A, Davis, JW. Intraoperative Evaluation and Management of High-Risk Prostate Cancer during Robot-Assisted Radical Prostatectomy, 241-249, 2022.
4. Davis, JW, Urkmez, A. Extended Lymphadenectomy Technique, 227-233, 2021.

Books (edited and written)

1. Davis JW, et al. Robot-Assisted Radical Prostatectomy: Beyond the Learning Curve. Ed(s) 1st. Springer International Publishing AG, Cham. 2016.